Mergers & Acquisitions

CVS Health said that it plans to acquire or take a stake in a primary care company by the end of the year.

Despite facing a challenging economic environment, CVS Health’s Q2 revenues increased to $80.6 billion, up 11% compared with the prior year period.

​​​​​​​Selected generic manufacturers will have the opportunity to develop, manufacture and supply generic versions of cabotegravir LA for PrEP, the first long-acting HIV prevention medicine, in 90 countries.

Velcade is used to treat adults with multiple myeloma, a cancer of the plasma cells. It also is used to treat adults with mantle cell lymphoma, a cancer of the lymph nodes.

Ana Chadwick, Pitney Bowes executive vice president and chief financial officer, has joined Dollar General’s board.

The 350,000-sq.-foot customer fulfillment center has brought more than 500 new jobs to Dallas and the surrounding communities, and enables Kroger Delivery to expand its services to more customers. 

Aaron Wiese will become Hy-Vee’s next CEO, effective Oct. 1. Jeremy Gosch will remain president and chief operating officer.

Sun Pharma and Cassiopea will bring Winlevi to patients in Japan, Australia, New Zealand, Brazil, Mexico and Russia.